Published in Acta Neuropsychiatr on November 21, 2016
Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci (2007) 19.58
How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci (2002) 15.88
Empathy for pain involves the affective but not sensory components of pain. Science (2004) 11.33
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Does rejection hurt? An FMRI study of social exclusion. Science (2003) 10.81
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry (2003) 10.07
Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin (2000) 6.58
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry (2015) 5.38
The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev (2011) 5.25
The neural correlates of maternal and romantic love. Neuroimage (2004) 4.70
Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci (2011) 4.26
Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction (2004) 2.97
Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry (2009) 2.95
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology (2004) 2.87
Object-based auditory and visual attention. Trends Cogn Sci (2008) 2.79
The endocannabinoid system and the brain. Annu Rev Psychol (2012) 2.26
Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci (2004) 2.10
Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. Lancet Psychiatry (2016) 2.04
From prediction error to incentive salience: mesolimbic computation of reward motivation. Eur J Neurosci (2012) 2.02
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci (2006) 1.96
Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res (2005) 1.89
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology (2008) 1.88
Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage (2004) 1.74
Marijuana craving in the brain. Proc Natl Acad Sci U S A (2009) 1.62
Cannabinoid transmission and reward-related events. Neurobiol Dis (1998) 1.62
Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci (2008) 1.55
The role of the insula in schizophrenia. Schizophr Res (2010) 1.52
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology (2008) 1.49
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry (2009) 1.40
Aberrant salience network (bilateral insula and anterior cingulate cortex) connectivity during information processing in schizophrenia. Schizophr Res (2010) 1.39
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol (2008) 1.39
Elevated endogenous cannabinoids in schizophrenia. Neuroreport (1999) 1.38
Aberrant dependence of default mode/central executive network interactions on anterior insular salience network activity in schizophrenia. Schizophr Bull (2013) 1.35
Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl) (1990) 1.32
Extended amygdala and emotional salience: a PET activation study of positive and negative affect. Neuropsychopharmacology (2002) 1.29
Psychophysiological responses to drug-associated stimuli in chronic heavy cannabis use. Eur J Neurosci (2008) 1.23
Dopaminergic basis of salience dysregulation in psychosis. Trends Neurosci (2014) 1.15
Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol Psychiatry (2013) 1.14
Neuropsychological deficits associated with cannabis use in young adults. Drug Alcohol Depend (2011) 1.12
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry (2012) 1.07
Evidence for a general face salience signal in human amygdala. Neuroimage (2010) 1.06
Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psychopharmacology (Berl) (1987) 1.02
Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats. Br J Pharmacol (1999) 1.01
Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacology (2013) 0.99
Salience and psychosis: moving from theory to practise. Psychol Med (2008) 0.92
Psychobiological responses to unpleasant emotions in cannabis users. Eur Arch Psychiatry Clin Neurosci (2011) 0.90
Cannabis abstinence during treatment and one-year follow-up: relationship to neural activity in men. Neuropsychopharmacology (2014) 0.85
Unravelling the intrinsic functional organization of the human striatum: a parcellation and connectivity study based on resting-state FMRI. PLoS One (2014) 0.84
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. J Psychopharmacol (2012) 0.84
Acute and non-acute effects of cannabis on human memory function: a critical review of neuroimaging studies. Curr Pharm Des (2014) 0.83
Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: preliminary results. Psychiatry Res (2013) 0.82
Marijuana's acute effects on cognitive bias for affective and marijuana cues. Exp Clin Psychopharmacol (2015) 0.82
Psychopharmacology of the endocannabinoids: far beyond anandamide. J Psychopharmacol (2011) 0.81
Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults. J Neurosci (2015) 0.81
Cannabinoid modulation of functional connectivity within regions processing attentional salience. Neuropsychopharmacology (2014) 0.81
Affective salience can reverse the effects of stimulus-driven salience on eye movements in complex scenes. Front Psychol (2012) 0.80
Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. Eur Neuropsychopharmacol (2015) 0.80
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids. Psychol Med (2015) 0.79
Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC). Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.77
Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis. Eur Neuropsychopharmacol (2014) 0.76